戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ropose to rename yegMNOB as mdtABCD (mdt for multidrug transporter).
2 nce of NorA functioning as a self-sufficient multidrug transporter.
3 nhibitors in the body may be affected by the multidrug transporter.
4 lysis to drug pumping by P-glycoprotein, the multidrug transporter.
5 ay be involved in the phosphorylation of the multidrug transporter.
6 lyspecific drug binding pocket in this yeast multidrug transporter.
7 ence that caspofungin is not a substrate for multidrug transporters.
8 iosynthesis enzymes or altered expression of multidrug transporters.
9 hodamine 123 (Rho-123), another substrate of multidrug transporters.
10  can have broad specificity, as in so-called multidrug transporters.
11  of its mammalian counterparts and bacterial multidrug transporters.
12 on, thus expanding the substrate spectrum of multidrug transporters.
13 ecificity of this protein and possibly other multidrug transporters.
14 velopment of novel specificities in existing multidrug transporters.
15  the exceptional promiscuous capabilities of multidrug transporters.
16  and anionic lipids on the activity of these multidrug transporters.
17 ta lmrA Delta lmrCD lacking major endogenous multidrug transporters.
18 ral operons encoding confirmed and predicted multidrug transporters.
19 nts, has been compromised by the presence of multidrug transporters.
20 op are divergent from those of the bacterial multidrug transporters.
21 e receptors, along with the participation of multidrug transporters, 5-lipoxygenase, and G protein-co
22 scent of those of other ATP-binding cassette multidrug transporters: a relatively high Km for ATP (1.
23 lso significant inhibitory power against the multidrug transporter ABCB1 and showed to reverse ABCB1-
24 ane in hepatocytes, highly homologous to the multidrug transporter ABCB1.
25 tral regulator of xenobiotic defense via the multidrug transporter ABCB1/MDR1 p-gp.
26 ABCB4 shares high sequence identity with the multidrug transporter, ABCB1, its N-terminal domain is p
27 2-driven migration through activation of the multidrug transporters, Abcb1 and Abcc1, and through 5-l
28                Here we report that the major multidrug transporter ABCG2 (BCRP/MXR) is directly and s
29 for resistance-nodulation-cell division-type multidrug transporters, abolished the BaeR-induced incre
30 n Escherichia coli, there are at least three multidrug transporters (AcrAB/TolC, MdfA, and NorE) that
31 onally important switch loop of the trimeric multidrug transporter AcrB separates the access and deep
32                                        MtaN (Multidrug Transporter Activation, N terminus) is a const
33 ity for MDR1 substrates, but it did not have multidrug transporter activity.
34 sult, is important for the distribution of a multidrug transporter and hence sensitivity to antifunga
35 us thermophilus; it is homologous to various multidrug transporters and contains one degenerate site
36 nding other questions about the evolution of multidrug transporters and their natural physiological r
37 esistance genes in the whiB7 regulon, tap (a multidrug transporter) and erm(37) (a ribosomal methyltr
38  not meiotic mapping could exclude the Abcc1 multidrug transporter, and this was confirmed further by
39                                              Multidrug transporters are integral membrane proteins th
40                   ATP-binding cassette (ABC) multidrug transporters are large, polytopic membrane pro
41 istance in this tumor type and defining this multidrug transporter as a target for pharmacologic supp
42 gemcitabine effectiveness by down-regulating multidrug transporters as well by converting gemcitabine
43                                 Induction of multidrug transporters at blood-brain barrier can largel
44  a 4-fold stimulation of the P-glycoprotein (multidrug transporter) ATPase.
45 yaluronan receptor CD44 forms complexes with multidrug transporters, BCRP (ABCG2) and P-glycoprotein
46 ichia coli is a prototypical H(+) -dependent multidrug transporter belonging to the Major Facilitator
47 st promising theory is the overexpression of multidrug transporters belonging to ATP-binding cassette
48                                              Multidrug transporters belonging to the multidrug and to
49 n of the gene encoding the Bacillus subtilis multidrug transporter Blt suggests a specific function f
50 mbrane proline P347 of the Bacillus subtilis multidrug transporter Bmr significantly increases the to
51                        The Bacillus subtilis multidrug transporter Bmr, a member of the major facilit
52 pon drug binding activates expression of the multidrug transporter Bmr.
53                                          The multidrug transporters breast cancer resistance protein
54                                          The multidrug transporter, breast cancer resistance protein,
55 ed to homology model human and microbial ABC multidrug transporters by computational methods, the abi
56                                   Individual multidrug transporters can be extremely versatile, often
57 The similarly broad substrate specificity of multidrug transporters can be governed by the same struc
58                                              Multidrug transporters can confer drug resistance on cel
59 mical-induced accumulation of several binary multidrug transporter complexes that largely paralleled
60 ional (3D) structure of the Escherichia coli multidrug transporter EmrE by electron cryomicroscopy of
61 olled, efficient reconstitution of the small multidrug transporter EmrE in a simple model membrane an
62                   We have refolded the small multidrug transporter EmrE in vitro from a denatured sta
63                                The bacterial multidrug transporter EmrE is a dual-topology membrane p
64 drug-proton exchange in the Escherichia coli multidrug transporter, EmrE.
65                          P-glycoprotein is a multidrug transporter encoded by the MDR1 gene.
66                   Furthermore, the number of multidrug transporters encoded in each genome is so larg
67 candin resistance via negative regulation of multidrug transporter-encoding and ergosterol biosynthes
68 glycoprotein (Pgp), the ATP-binding cassette multidrug transporter, exhibits a drug (substrate)-stimu
69 eptor kinases or anti-apoptotic pathways and multidrug transporter expression or function.
70                                   Typically, multidrug transporters feature spacious, dynamic, and ch
71                                    The small multidrug transporter from Escherichia coli, EmrE, coupl
72                                      EmrE, a multidrug transporter from Escherichia coli, functions a
73      LmrP is a major facilitator superfamily multidrug transporter from Lactococcus lactis that media
74                                    EmrD is a multidrug transporter from the Major Facilitator Superfa
75                               Similar to the multidrug transporters from eukaryotic cells and Gram-po
76                                         Many multidrug transporters from gram-negative bacteria belon
77 ein QacR represses transcription of the qacA multidrug transporter gene and is induced by multiple st
78 ein QacR represses transcription of the qacA multidrug transporter gene and is induced by structurall
79          BmrR activates transcription of the multidrug transporter gene, bmr, in response to cellular
80 GF-R) activation and the expression of ABCC1 multidrug transporter gene, thus contributing to tumor c
81 zole resistance is upregulated expression of multidrug transporter genes CDR1 and PDH1.
82 ns specificity for other known substrates of multidrug transporters has never been tested.
83                                     RND-type multidrug transporters have an extremely broad substrate
84 ditionally, advances in the understanding of multidrug transporters have been made through biochemica
85                                              Multidrug transporters have long puzzled researchers bec
86                              EmrE is a small multidrug transporter in Escherichia coli that extrudes
87 reveal the natural function of the system of multidrug transporters in B. subtilis and serve as a par
88 st prescribed first- and second-line AEDs on multidrug transporters in human cerebral microvascular e
89 ial challenges alter expression of placental multidrug transporters in rodents.
90 known regulator of the expression of several multidrug transporters in Staphylococcus aureus.
91 -dependent transport kinetics of MexAB-OprM (multidrug transporter) in Pseudomonas aeruginosa in real
92 ast to the behavior observed with some other multidrug transporters, including OCT2, the results sugg
93 se inhibition of transport activity of other multidrug transporters, including the organic cation tra
94 lastine, and rifampicin) of the well studied multidrug transporters inhibit DrrAB-mediated Dox transp
95 mission in mammalian organisms and bacterial multidrug transporters involved in antibiotic resistance
96  discuss recent structural investigations of multidrug transporters involved in resistance to infecti
97                               The yeast Pdr5 multidrug transporter is an important member of the ATP-
98 exity, the mechanism of Hoechst transport by multidrug transporters is poorly characterised.
99 active efflux of cytotoxic drugs mediated by multidrug transporters is the basis of multidrug resista
100 as suggested that P-glycoprotein (P-gp), the multidrug transporter, is phosphorylated by protein kina
101            The major facilitator superfamily multidrug transporter LmrP from Lactococcus lactis catal
102                                 The paradigm multidrug transporter, mammalian P-glycoprotein, was ide
103                         The Escherichia coli multidrug transporter MdfA exchanges a single proton wit
104  can be restored either by expression of the multidrug transporter MdfA from a multicopy plasmid or b
105 ution structure of the detergent-solubilized multidrug transporter MdfA from E. coli.
106 drug conjugates (ADC) are substrates for the multidrug transporter MDR1.
107 he close functional relationship between the multidrug transporter (MDR1) and phosphatidylcholine fli
108 at-3-specific transcriptional activation and multidrug transporter, MDR1 (P-glycoprotein) gene expres
109 ositide 3-kinase stimulate expression of the multidrug transporter, MDR1 (P-glycoprotein), in an inte
110 on microscopy structures of Escherichia coli multidrug transporter MdtF within native-lipid nanodiscs
111 al and molecular evidence for acquisition of multidrug transporter-mediated efflux activity as a cons
112 xpenditure to substrate translocation in the multidrug transporter MsbA.
113  structural and biochemical data for several multidrug transporters now provide mechanistic insights
114 issect genetically the regulation of NorA, a multidrug transporter of Staphylococcus aureus, we analy
115 thin Lactococcus lactis LmrP, a prototypical multidrug transporter of the major facilitator superfami
116                          EmrE is a bacterial multidrug transporter of the small multidrug resistance
117         The expression of two highly similar multidrug transporters of Bacillus subtilis, Bmr and Blt
118 ly been seen in ion channels but is known in multidrug transporters of the SMR family, and is suggest
119  mice, were used to study the effects of the multidrug transporters on the pharmacokinetics of PhIP a
120 quently attributed to enhanced expression of multidrug transporters or to the action of receptor kina
121                   Co-expression of the human multidrug transporter P-glycoprotein (of which both drug
122 obe the substrate binding sites of the human multidrug transporter P-glycoprotein (P-gp).
123                                          The multidrug transporter P-glycoprotein (P-gp, ABCB1) is an
124                                          The multidrug transporter P-glycoprotein (Pgp) is an ATPase
125 everse drug resistance mediated by the human multidrug transporter P-glycoprotein (Pgp) with a stereo
126          The reactivity of the ATP-dependent multidrug transporter P-glycoprotein (Pgp) with the conf
127 SA), which is a competitive inhibitor of the multidrug transporter p-glycoprotein (pgp).
128 ), the rat parallel to human CYP3A4, and the multidrug transporter P-glycoprotein (Pgp).
129                                    The human multidrug transporter P-glycoprotein (Pgp, ABCB1) contri
130 inding cassette subfamily B member 1 (ABCB1) multidrug transporter P-glycoprotein plays a central rol
131  analogue PSC 833, a potent inhibitor of the multidrug transporter P-glycoprotein.
132                                     The MDR1 multidrug transporter P-gp (P-glycoprotein) is an efflux
133 otease inhibitors are recognized by the MDR1 multidrug transporter (P-glycoprotein, or P-gp), thereby
134 st phase (CML-BP) cells commonly express the multidrug transporter, P-glycoprotein (Pgp).
135                                          The multidrug transporter, P-glycoprotein, expressed at the
136 as been determined for the NBDs of the human multidrug transporter, P-glycoprotein.
137 haracterized a mutation (S558Y) in the yeast multidrug transporter Pdr5 that uncouples ATP hydrolysis
138 f residues in the gating region of the yeast multidrug transporter Pdr5, the founding member of a lar
139 he putative drug-binding pocket of the yeast multidrug transporter Pdr5.
140         The yeast (Saccharomyces cerevisiae) multidrug transporter Pdr5p effluxes a broad range of su
141 The yeast ABC (ATP-binding cassette protein) multidrug transporter Pdr5p transports a broad spectrum
142  the protonation-dependent transition of the multidrug transporter PfMATE to an inward facing conform
143                                              Multidrug transporters prompt multidrug resistance by ex
144                                              Multidrug transporters pump structurally dissimilar toxi
145  As opposed to the majority of inhibitors of multidrug transporters, Reversan was not toxic by itself
146 rlR and brlR expression are not activated by multidrug transporter substrates.
147  caused by overexpression or overactivity of multidrug transporters, such as P-glycoprotein (P-gp), a
148         Low-resolution structural studies of multidrug transporters suggest that they possess similar
149 tease inhibitors are substrates of the human multidrug transporter, suggesting that cells in patients
150                  EmrE, a member of the small multidrug transporters superfamily, extrudes positively
151 ein (BCRP; ABCG2) is an ATP-dependent efflux multidrug transporter that belongs to the G family of ha
152   P-glycoprotein (Pgp) is an important human multidrug transporter that contributes to pharmacokineti
153                   P-glycoprotein (P-gp) is a multidrug transporter that is expressed on the luminal s
154                   P-glycoprotein (P-gp) is a multidrug transporter that uses energy from ATP hydrolys
155                                    EmrE is a multidrug transporter that utilises the proton gradient
156  of multidrug resistance (MDR) is a group of multidrug transporters that are often regulated at the t
157     VMAT2 is a member of the DHA12 family of multidrug transporters that belongs to the major facilit
158     VMAT2 is a member of the DHA12 family of multidrug transporters that belongs to the major facilit
159      EmrE belongs to a family of eubacterial multidrug transporters that confer resistance to a wide
160                     Bacteria express several multidrug transporters that recognize structurally dissi
161    The efflux of chemically diverse drugs by multidrug transporters that span the membrane is one mec
162           In the well studied P-glycoprotein multidrug transporter, the two appear to be functionally
163                                   Unlike the multidrug transporters, the cytosolic multidrug-binding
164 aspects of the transformation of a bacterial multidrug transporter to a mammalian neurotransporter an
165                                    Secondary multidrug transporters use ion concentration gradients t
166 , in response, activates the expression of a multidrug transporter which expels them out of the cell.
167 (VMAT2) has sequence homology with bacterial multidrug transporters which in turn share homology with
168 ent manner the photoaffinity labeling of the multidrug transporter with 125I-iodoarylazidoprazosin an

 
Page Top